Abstract:The Wnt/β-catenin signaling pathway has been implicated as the central mechanism that drives colorectal carcinogenesis. Its activation is historically due to mutation on APC (adenomatous polyposis coli), resulting to nuclear localization of β-catenin and expression of Wnt target genes that promote tumor progression. Although this pathway seems to be a pivotal therapeutic target because of its critical role in colorectal cancer, there has been no clinically approved therapies targeting Wnt/β-catenin signaling pathway to this date. Here, we reviewed the recent progress of this signal transduction pathway in colorectal tumorigenesis. Apart from their roles in cancer initiation, the new pathway modulators (activators and repressors) also participate in chemoresistance, epithelial-mesenchymal transition and cancer stem cell renewal. Of the proteins reported to modulate this pathway, CDX2 (Caudal-related homeobox transcription factor 2) showed potentials as promising molecular target. CDX2 warrants further studies to determine its significance as molecular target for colorectal cancer therapeutics. Overall, the regulation of Wnt/β-catenin signaling pathway remains intriguingly complex and is not fully understood in spite of the widespread research efforts. Its intricacy remains a major barrier in the development of chemotherapeutic agent that specifically targets it.

Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy.

[Crosstalk Between Canonical TGF-β/Smad and Wnt/β-catenin Signaling Pathway].

Wnt/β-catenin Singal Transduction Pathway and Colorectal Cancer

Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis.

Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy

Wnt signaling in colorectal cancer: pathogenic role and therapeutic target

Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?

Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer

Crosstalk Between Tumor Cells and Microenvironment Via Wnt Pathway in Colorectal Cancer Dissemination

Crosstalk between circRNAs and the PI3K/AKT and/or MEK/ERK signaling pathways in digestive tract malignancy progression

Silencing Of Brain-Expressed X-Linked 2 (Bex2) Promotes Colorectal Cancer Metastasis Through The Hedgehog Signaling Pathway

Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination.

Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities

Wnt/β-catenin Signaling Pathway and Gastric Cancer

Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

Crosstalk of the Wnt/β-Catenin Signaling Pathway in the Induction of Apoptosis on Cancer Cells

The regulation of β-catenin activity and function in cancer: therapeutic opportunities

Targeting the most upstream site of Wnt signaling pathway provides a strategic advantage for therapy in colorectal cancer.

[Crosstalk of Hippo/YAP and Wnt/β-catenin Pathways].

Crosstalk between lncRNAs and Wnt/β-catenin signaling pathways in lung cancers: From cancer progression to therapeutic response